SalaryGuide
AboutPricingFor Employers

Marketing jobs

1 marketing jobs

Pfizer logo
7 weeks ago

Senior Director, CFC CRM Lifecycle & Value Lead

Pfizer

East Riding of Yorkshire, UK (Hybrid)Full time$215K/yr – $358K/yr

Find marketing roles you could actually win

1 open roles0

Popular searches:

Growth MarketingHead of MarketingSEO ManagerProduct MarketingPaid MediaBrand Manager
Growth MarketingHead of MarketingPerformance MarketingContent StrategySEO ManagerProduct MarketingDemand GenerationBrand ManagerPaid MediaMarketing AnalyticsCRM ManagerSocial Media

Find marketing roles you could actually win

1 open roles0

Popular searches:

Growth MarketingHead of MarketingSEO ManagerProduct MarketingPaid MediaBrand Manager
Growth MarketingHead of MarketingPerformance MarketingContent StrategySEO ManagerProduct MarketingDemand GenerationBrand ManagerPaid MediaMarketing AnalyticsCRM ManagerSocial Media
1 jobs
Pfizer logo

Senior Director, CFC CRM Lifecycle & Value Lead

Pfizer

East Riding of Yorkshire, UK (Hybrid)

$215K/yr - $358K/yrIn-houseFull-timeSenior level12+ years exp.
7 weeks ago
Pfizer logo
Pfizer

Senior Director, CFC CRM Lifecycle & Value Lead

East Riding of Yorkshire, UK (Hybrid)

$215K/yr – $358K/yrSenior Level12+ years expFull time

Posted 7 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own global CRM BAU, governance, and roadmaps for a complex CFC ecosystem to drive adoption and commercial impact across markets.

  • Cross‑functional orchestration: single BAU point for Commercial, Medical, CMO, Digital, Data, Compliance, and Markets.
  • Platform health & value: define metrics, ensure availability, and realize value from CRM investments.
  • Roadmap to operations: partner with Product leadership and own post‑launch sustainment and handover.

Job Description

Responsibilities

  • Own the post‑launch lifecycle management of CFC CRM across global markets.
  • Be accountable for platform availability, reliability, performance, and scalability.
  • Manages current CFC CRM ecosystem roadmaps & coexistence with legacy CRM environments, ensuring continuity, direction and risk mitigation.
  • Make trade‑off decisions where precedent may not exist with stakeholder input
  • Drive measurable value realization from CRM investments (adoption, productivity, commercial impact).
  • Establish level metrics and reporting for BAU health and value delivery within the CFC technology ecosystem
  • Ensure CRM outcomes align to commercial strategy, not just technology success.
  • Define and mature the global CFC CRM operating model & governance, balancing innovation with stability.
  • Own technology BAU roadmap across support, enhancements, release readiness, and optimization.
  • Reduce market‑by‑market variance through harmonization and repeatable patterns.

Requirements

  • BA Required; MBA or equivalent Master’s-level education preferred
  • A minimum of 12+ years of experience in the pharmaceutical industry, preferably in managing diverse/global teams
  • Demonstrated capability in carrying out process excellence, knowledge management and project management.
  • Demonstrated experience working and/or supporting global or above markets.
  • Experience leading and understanding agile ways of working and product development lifecycle.
  • Ability to navigate consumer privacy and / or healthcare data landscape at scale
  • Deep understanding and passion for CRM and content platforms, technologies (especially in areas across Customer-facing colleagues)

Preferred

  • Experience working with engineering teams in designing scalable architecture that meets the needs of marketing and sales co-workers.
  • Experience evaluating product decisions strategically and making prioritization tradeoffs, leveraging large datasets to make data driven product decisions while collaborating with multiple stakeholders and cross functional teams.
  • Strong writing, presentation and influencing skills.

Benefits

  • We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments.
  • Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage.
Pfizer logo

Pfizer

We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines

New York, New York, USA
102K employees (4,879 in marketing)
www.pfizer.com/?source=Linkedin

Traffic Signals

Monthly Visitors
2.3M
Monthly Google Ads Budget
$117.8K
Traffic Source Mix
Search
54.8%
Direct
34.7%
Referral
8%
Social
1.4%
Paid
1%

Headcount Trend

Current headcount: ~102.3K

Marketing Team

Marketing Team Size
4,125 (4% of company)
Median Career Experience
17.5 years
Median Tenure
6.4 years
Marketing Roles Posted (Last 30 Days)
3

People

HR / Recruitment

Sergey Arzamastsev
Sergey Arzamastsev
Senior Director, People Experience, Chief Marketing Office and Global Talent Solutions
At the company for 16 years 5 months
Anne Kennedy Dotson
Anne Kennedy Dotson
Head of Global Employer Brand, Recruitment Marketing & University Relations
At the company for 6 years 5 months

Marketing Leadership

Emily Friedman
Emily Friedman
Vice President Brand Marketing
At the company for 3 years 2 months
Nitin Mahadev
Nitin Mahadev
Vice President and Global Marketing Head for the Rare Disease Franchise
At the company for 17 years 6 months
Nana Danso
Nana Danso
Vice President, US Dermatology Marketing Lead
At the company for 8 years 3 months
Amanda Daniels
Amanda Daniels
Vice President Global Marketing, Cibinqo, Eucrisa & Brepocitinib
At the company for 18 years 10 months

Funding

Total Funding
$38B
Last Raise
$6B
Post IPO Debt, 4 months ago

Funding History

  • Nov 2025
    Post IPO Debt • $6B
  • Oct 2024
    Post IPO Equity • $1B
  • May 2023
    Post IPO Debt • $31B

Recent News

Drug Prices: Will the New Pfizer Deal Lower Costs for Americans?
Oct 5, 2025 • National Academy of Medicine
Health Answers by Pfizer Launches Spanish-Language Expansion
Oct 3, 2025 • Pfizer
Pfizer’s Drug Price Cuts Yield Three-Year Trump Tariff Reprieve
Oct 1, 2025 • Yahoo Finance
Pfizer's drug pricing deal with Trump ratchets up pressure on other pharma companies
Oct 1, 2025 • Axios
President Trump announces deal with Pfizer to sell its drugs on federal website
Oct 1, 2025 • NPR
Pfizer strikes deal with Trump administration to cut US drug prices
Oct 1, 2025 • Al Jazeera
Trump announces deal with Pfizer to lower drug prices, including 'TrumpRx' website
Sep 30, 2025 • NBC News
Administration announces agreement with Pfizer to lower drug costs
Sep 30, 2025 • American Hospital Association
Pfizer to offer cheaper US drugs via Trump's website in new deal
Sep 30, 2025 • BBC
Pfizer, Trump strike drug pricing deal
Sep 30, 2025 • Politico
Trump announces ‘TrumpRx’ site for discounted drugs and deal with Pfizer to lower prices
Sep 30, 2025 • CNN
US drugmakers rise after Trump announces Pfizer price cuts
Sep 30, 2025 • Reuters
White House Unveils ‘TrumpRx’ Drug-Buying Site and a Pfizer Pricing Deal
Sep 30, 2025 • The Wall Street Journal
Trump, Pfizer, and the art of a drug pricing deal
Sep 30, 2025 • statnews.com
Pfizer agrees to offer discounted drugs through new federal website, Trump announces
Sep 30, 2025 • The Guardian
Trump Announces Deal With Pfizer to Sell Drugs to Medicaid at European Prices
Sep 30, 2025 • The New York Times
President announces TrumpRx website for drugs, and pricing deal with Pfizer
Sep 30, 2025 • NPR
Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump
Sep 30, 2025 • AP News
WATCH: Trump announces Pfizer deal to lower drug prices
Sep 30, 2025 • PBS
Sanders report finds nearly 700 prescription drugs have increased in price under Trump
Sep 29, 2025 • vermontbiz.com
World shares trade mostly higher after Wall Street snaps its 3-day losing streak
Sep 29, 2025 • BNN Bloomberg
United States Cancer Therapeutics Market to Hit $491.6 Billion by 2032, Driven by Precision and Immunotherapy Advances
Sep 29, 2025 • EIN Presswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
Sep 29, 2025 • PR Newswire
Walmsley’s Dream Hire Badly Needs to Find Some Blockbuster Drugs
Sep 29, 2025 • Livemint.com
Genmab Buys Rising Cancer Star Merus for $8B
Sep 29, 2025 • BioSpace
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
Sep 29, 2025 • BioSpace
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
Sep 29, 2025 • MarketScreener
Hundreds Attend IRA Implementation Summit; Uncertainties, Confusion and Concerns About Service Levels Underscore Dialogue
Sep 29, 2025 • BioSpace
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
Sep 29, 2025 • BioSpace
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, HOUS, ODP on Behalf of Shareholders
Sep 29, 2025 • Halper Sadeh LLC
5 Dividend Powerhouses to Buy and Never Sell
Sep 28, 2025 • The Motley Fool
Why Pfizer's Post-COVID Future Looks Brighter Than Ever
Sep 28, 2025 • The Motley Fool
Down 55%, Should You Buy the Dip on Pfizer?
Sep 28, 2025 • The Motley Fool
Pfizer sued in US over contraceptive that women say caused brain tumours
Sep 28, 2025 • Yahoo Finance - Business Finance, Stock Market, Quotes, News
Why Pfizer's Post-COVID Future Looks Brighter Than Ever
Sep 28, 2025 • Yahoo Finance
Key facts: President Trump plans a 100% tariff on branded drugs, including Pfizer's, unless firms set up U.S. manufacturing plants to protect local producers from foreign imports.
Sep 28, 2025 • TradingView
Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet?
Sep 27, 2025 • The Motley Fool
3 Magnificent Stocks Under $100 to Buy Right Now
Sep 27, 2025 • The Motley Fool
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
Sep 27, 2025 • Halper Sadeh LLC
COVID-19 Vaccination Fall 2025/2026 Implementation Package
Sep 27, 2025 • City of Hamilton
Pfizer Faces Court Over Depo-Provera Brain Tumor Claims
Sep 26, 2025 • Benzinga.com
2 Top Passive Income Stocks to Buy Now
Sep 26, 2025 • The Motley Fool
Most of Wall Street ticks higher following its 3-day skid
Sep 26, 2025 • Houston Chronicle
Trump announces new tariffs on pharmaceuticals from October
Sep 26, 2025 • Irish Times
If you build it, tariffs won’t come: Pharma’s billion-dollar ultimatum
Sep 26, 2025 • Research & Development World
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
Sep 26, 2025 • Benzinga.com
Stocks rising after Trump announces new tariffs on furniture, drugs, trucks and cabinets
Sep 26, 2025 • mlive
BMS adds discounted psoriasis drug to its DTC channel
Sep 26, 2025 • pharmaphorum
Stock market rises and snaps out of its 3-day losing streak
Sep 26, 2025 • The Blade
3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now
Sep 26, 2025 • The Motley Fool
US FDA approves Crinetics' oral pill for rare hormone disorder
Sep 25, 2025 • Reuters
STAT+: Pharmalittle: We’re reading about a PBM makeover plan, a Bristol cash-pay plan, and much more
Sep 25, 2025 • STAT
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
Sep 25, 2025 • BioSpace
Sethera Therapeutics Appoints Jeffery W. Kelly and Alexander M. Klibanov to Scientific Advisory Board
Sep 25, 2025 • EIN Presswire
Pfizer-backed biotech readies expansion after trial success
Sep 25, 2025 • Seattle TechFlash
LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani
Sep 25, 2025 • LB Pharmaceuticals Inc.
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
Sep 25, 2025 • BioSpace
Does This Acquisition Make Pfizer Stock a Great Buy?
Sep 25, 2025 • The Motley Fool
FDA’s Autism Endeavor, Pfizer’s Obesity Comeback Bid, Psychedelics Revival, ACIP Confusion, More
Sep 24, 2025 • BioSpace
Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts
Sep 24, 2025 • BioSpace
Autozone, Pfizer, Valley National Bancorp
Sep 24, 2025 • Reuters
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
Sep 24, 2025 • Zealand Pharma
TOMI Environmental Solutions Announces Specialized Service Provider for Healthcare and Mold Remediation
Sep 24, 2025 • TOMI Environmental Solutions, Inc.
Pfizer moves to acquire Metsera in bold re entry into obesity drug race
Sep 24, 2025 • PharmiWeb
FNIH Names David Liu, PhD, as Recipient of Inaugural Montrone-Seigel Prize in Biomedical Sciences
Sep 23, 2025 • citybiz
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders
Sep 23, 2025 • Halper Sadeh LLC
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, ODP, SMLR on Behalf of Shareholders
Sep 23, 2025 • Halper Sadeh LLC
Asian shares trade mixed after US stocks set more records
Sep 23, 2025 • AP News
Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera
Sep 22, 2025 • CNBC
Pfizer doubles down on weight-loss treatments with up to $7.3 billion Metsera buyout
Sep 22, 2025 • Reuters
Pfizer to buy obesity-focused Metsera in $4.9 billion deal
Sep 22, 2025 • statnews.com
Pfizer buys back into obesity drug chase with $4.9B Metsera deal
Sep 22, 2025 • BioPharma Dive
3 Bargain Stocks for Investors on a Budget
Sep 21, 2025 • The Motley Fool
Dollar weakness drives record US corporate euro bond issuance
Sep 21, 2025 • Cyprus Mail
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
Sep 20, 2025 • The Motley Fool
Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon
Sep 20, 2025 • The Motley Fool
Pharma company Pfizer to cut up to 58 jobs at headquarters in Brussels
Sep 19, 2025 • belganewsagency.eu
CDC panel votes to end universal Covid vaccine recommendation, Bloomberg says
Sep 19, 2025 • thefly.com
CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids
Sep 19, 2025 • Investor's Business Daily
Pfizer, BioNTech express dedication to making safe Covid vaccines
Sep 19, 2025 • thefly.com
Fierce Pharma Asia—BMS’ China asset sale; 2 biotech debuts; 2 potential deals
Sep 19, 2025 • FiercePharma
Takeaways from RFK Jr.'s vaccine panel meeting on COVID-19 and childhood vaccines
Sep 19, 2025 • AP News
Appendicitis Treatment Market Size to Reach USD 7.08 Billion by 2032 as AI-Powered Diagnostics and Non-Operative Management Transform Clinical Pathways | S&S Insider
Sep 17, 2025 • SNS Insider pvt ltd
Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party
Sep 17, 2025 • MarketScreener
Multinational antitrust reviews in pharma M&A
Sep 17, 2025 • Law.asia
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
Sep 17, 2025 • Arvinas Inc.
KAT6 Inhibitors Market Poised for Significant Growth During the Forecast Period (2025-2040) | DelveInsight
Sep 16, 2025 • PR Newswire UK
Pfizer appoints Rodrigo Puga as Cluster President for the Middle East, Russia & Africa
Sep 16, 2025 • Zawya.com
KAT6 Inhibitors Market Poised for Significant Growth During the Forecast Period (2025-2040) | DelveInsight
Sep 16, 2025 • PR Newswire
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Sep 16, 2025 • Benzinga.com
Pfizer Appoints Rodrigo Puga as Cluster President for the Middle East, Russia & Africa
Sep 16, 2025 • South Africa Today
Kennedy Names New ACIP Members as Panel Quiets COVID-19 Vaccine Developers Ahead of Meeting
Sep 16, 2025 • BioSpace
Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects
Sep 12, 2025 • Yahoo Finance
Pfizer reports strong phase 3 clinical data for 2025-26 COVID vaccine
Sep 9, 2025 • CIDRAP
RION Launches INTENT Biologics to Develop Late-Stage Clinical Exosome-Based Therapies in Inflammation & Immunology; Appoints Biopharma Veteran Suneet Varma as CEO
Sep 9, 2025 • Business Wire
Dow Jones Top Company Headlines at 3 AM ET: Anglo American, Teck to Merge, Creating Copper Giant | Mistral ...
Sep 9, 2025 • Morningstar.com
The Best Ultra-High-Yield Dividend Stock to Invest $1,000 in Right Now
Sep 9, 2025 • The Motley Fool
Dow Jones Top Company Headlines at 11 PM ET: OpenAI Executives Rattled by Campaigns to Derail For-Profit Restructuring | Microsoft ...
Sep 9, 2025 • Dow Jones Newswires
Pfizer's PREVNAR 20 Selected for Pneumococcal Public Immunization Program in British Columbia Français
Sep 9, 2025 • Canada NewsWire
Indian pharma sector needs price hikes, site and IP transfers to tackle US tariff uncertainty: Report
Sep 9, 2025 • Livemint.com